Search research articles
Contact Us
Filters
Showing results (511-520 of 768) with videos related to
Page
of 77
Sort By:
British Journal of Haematology
|
January 22, 2013
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation
Fleur M Aung, Benjamin Lichtiger, Roland Bassett, et al.
Blood
|
December 12, 2001
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
I F Khouri, R M Saliba, S A Giralt, et al.
Plos One
|
June 2, 2015
Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
Drew C Deniger, Jianqiang Yu, M Helen Huls, et al.
Bone Marrow Transplantation
|
March 30, 2004
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
U Popat, C Hosing, R M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2018
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation
Aimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2018
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
Jeff K Davies, Lisa L Brennan, John R Wingard, et al.
British Journal of Haematology
|
April 6, 2021
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era
Mithun V Shah, Rima M Saliba, Ankur Varma, et al.
Bone Marrow Transplantation
|
January 27, 2015
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts
G S Hobbs, A Hamdi, P D Hilden, et al.
Blood
|
June 4, 2020
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL
Neeraj Saini, David Marin, Celina Ledesma, et al.
Leukemia & Lymphoma
|
July 26, 2011
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
Qaiser Bashir, Nina Shah, Simrit Parmar, et al.
Page
of 77
Search research articles
Search
Showing results (511-520 of 768) with videos related to
Sort By:
Page
of 77
British Journal of Haematology
|
January 22, 2013
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation
Fleur M Aung, Benjamin Lichtiger, Roland Bassett, et al.
Blood
|
December 12, 2001
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
I F Khouri, R M Saliba, S A Giralt, et al.
Plos One
|
June 2, 2015
Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
Drew C Deniger, Jianqiang Yu, M Helen Huls, et al.
Bone Marrow Transplantation
|
March 30, 2004
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
U Popat, C Hosing, R M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2018
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation
Aimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2018
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
Jeff K Davies, Lisa L Brennan, John R Wingard, et al.
British Journal of Haematology
|
April 6, 2021
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era
Mithun V Shah, Rima M Saliba, Ankur Varma, et al.
Bone Marrow Transplantation
|
January 27, 2015
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts
G S Hobbs, A Hamdi, P D Hilden, et al.
Blood
|
June 4, 2020
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL
Neeraj Saini, David Marin, Celina Ledesma, et al.
Leukemia & Lymphoma
|
July 26, 2011
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
Qaiser Bashir, Nina Shah, Simrit Parmar, et al.
Page
of 77